Humana Inc. (HUM)
NYSE: HUM · IEX Real-Time Price · USD
355.43
-5.57 (-1.54%)
Jun 6, 2024, 4:00 PM EDT - Market closed
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Humana stock have an average target of 406.11, with a low estimate of 310 and a high estimate of 599. The average target predicts an increase of 14.26% from the current stock price of 355.43.
Analyst Consensus: Buy
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | $310 | $406.11 | $381 | $599 |
| Change | -12.78% | +14.26% | +7.19% | +68.53% |
Analyst Ratings
The average analyst rating for Humana stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 4 | 4 | 3 | 4 | 4 |
| Buy | 9 | 8 | 8 | 7 | 7 | 5 |
| Hold | 3 | 6 | 6 | 9 | 10 | 11 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 19 | 21 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold Initiates $374 | Hold | Initiates | $374 | +5.22% | May 30, 2024 |
| B of A Securities | B of A Securities | Hold Maintains $342 → $376 | Hold | Maintains | $342 → $376 | +5.79% | May 20, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $415 → $353 | Buy | Maintains | $415 → $353 | -0.68% | Apr 25, 2024 |
| UBS | UBS | Hold Maintains $334 → $326 | Hold | Maintains | $334 → $326 | -8.28% | Apr 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $391 → $360 | Hold | Maintains | $391 → $360 | +1.29% | Apr 25, 2024 |
Financial Forecast
Revenue This Year
115.12B
from 106.37B
Increased by 8.22%
from 106.37B
Revenue Next Year
116.55B
from 115.12B
Increased by 1.24%
from 115.12B
EPS This Year
16.56
from 20.00
Decreased by -17.21%
from 20.00
EPS Next Year
20.47
from 16.56
Increased by 23.63%
from 16.56
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 64.89B | 77.16B | 83.06B | 92.87B | 106.37B | 115.12B | 116.55B | 121.00B | 136.61B | 148.95B |
| Revenue Growth | 14.01% | 18.90% | 7.66% | 11.81% | 14.54% | 8.22% | 1.24% | 3.81% | 12.90% | 9.03% |
| EPS | 20.10 | 25.31 | 22.67 | 22.08 | 20.00 | 16.56 | 20.47 | 26.01 | 35.36 | 40.60 |
| EPS Growth | 65.30% | 25.92% | -10.43% | -2.60% | -9.42% | -17.21% | 23.63% | 27.05% | 35.95% | 14.83% |
| Forward PE | - | - | - | - | - | 21.47 | 17.36 | 13.67 | 10.05 | 8.75 |
| No. Analysts | - | - | - | - | - | 26 | 26 | 16 | 5 | 2 |
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 121.0B | 127.4B | 132.7B | 143.3B | 154.8B |
| Avg | 115.1B | 116.6B | 121.0B | 136.6B | 148.9B |
| Low | 110.9B | 108.6B | 111.2B | 130.9B | 144.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 13.7% | 10.7% | 13.8% | 18.4% | 13.3% |
| Avg | 8.2% | 1.2% | 3.8% | 12.9% | 9.0% |
| Low | 4.2% | -5.6% | -4.6% | 8.2% | 5.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 18.66 | 23.39 | 30.81 | 39.90 | 42.21 |
| Avg | 16.56 | 20.47 | 26.01 | 35.36 | 40.60 |
| Low | 15.68 | 17.69 | 20.58 | 32.19 | 39.40 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -6.7% | 41.3% | 50.5% | 53.4% | 19.4% |
| Avg | -17.2% | 23.6% | 27.0% | 36.0% | 14.8% |
| Low | -21.6% | 6.8% | 0.5% | 23.8% | 11.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.
